RESUMEN
Anxiety disorders are among the most prevalent categories of mental illnesses. The gut-brain axis, along with gastrointestinally-derived neuropeptides, like glucagon-like peptide-1 (GLP-1), are emerging as potential key regulators of emotionality, including anxiety behavior. However, the neuroanatomical substrates from which GLP-1 exerts its anxiogenic effect remain poorly characterized. Here we focus on a relatively new candidate nucleus, the supramammillary nucleus (SuM), located just caudal to the lateral hypothalamus and ventral to the ventral tegmental area. Our focus on the SuM is supported by previous data showing expression of GLP-1R mRNA throughout the SuM and activation of the SuM during anxiety-inducing behaviors in rodents. Data show that chemogenetic activation of neurons in the SuM results in an anxiolytic response in male and female rats. In contrast, selective activation of SuM GLP-1R, by microinjection of a GLP-1R agonist exendin-4 into the SuM resulted in potent anxiety-like behavior, measured in both open field and elevated plus maze tests in male and female rats. This anxiogenic effect of GLP-1R activation persisted after high-fat diet exposure. Importantly, reduction of GLP-1R expression in the SuM, by AAV-shRNA GLP-1R knockdown, resulted in a clear anxiolytic response; an effect only observed in female rats. Our data identify a new neural substrate for GLP-1 control of anxiety-like behavior and indicate that the SuM GLP-1R are sufficient for anxiogenesis in both sexes, but necessary only in females.
Asunto(s)
Ansiedad/psicología , Receptor del Péptido 1 Similar al Glucagón/fisiología , Hipotálamo Posterior/fisiología , Animales , Ansiedad/genética , Ansiedad/fisiopatología , Reacción de Prevención/efectos de los fármacos , Reacción de Prevención/fisiología , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Exenatida/farmacología , Femenino , Técnicas de Silenciamiento del Gen , Péptido 1 Similar al Glucagón/farmacología , Receptor del Péptido 1 Similar al Glucagón/antagonistas & inhibidores , Receptor del Péptido 1 Similar al Glucagón/genética , Hipotálamo Posterior/efectos de los fármacos , Masculino , ARN Interferente Pequeño/farmacología , Ratas , Ratas Sprague-Dawley , Ratas TransgénicasRESUMEN
γ-Melanocyte stimulating hormone (γ-MSH) is an endogenous agonist of the melanocortin 3-receptor (MC3R). Genetic disruption of MC3Rs increases adiposity and blunts responses to fasting, suggesting that increased MC3R signaling could be physiologically beneficial in the long term. Interestingly, several studies have concluded that activation of MC3Rs is orexigenic in the short term. Therefore, we aimed to examine the short- and long-term effects of γ-MSH in the hypothalamic arcuate nucleus (ARC) on energy homeostasis and hypothesized that the effect of MC3R agonism is dependent on the state of energy balance and nutrition. Lentiviral gene delivery was used to induce a continuous expression of γ-Msh only in the ARC of male C57Bl/6N mice. Parameters of body energy homeostasis were monitored as food was changed from chow (6 weeks) to Western diet (13 weeks) and back to chow (7 weeks). The γ-MSH treatment decreased the fat mass to lean mass ratio on chow, but the effect was attenuated on Western diet. After the switch back to chow, an enhanced loss in weight (−15% vs −6%) and fat mass (−37% vs −12%) and reduced cumulative food intake were observed in γ-MSH-treated animals. Fasting-induced feeding was increased on chow diet only; however, voluntary running wheel activity on Western diet was increased. The γ-MSH treatment also modulated the expression of key neuropeptides in the ARC favoring weight loss. We have shown that a chronic treatment intended to target ARC MC3Rs modulates energy balance in nutritional state-dependent manner. Enhancement of diet-induced weight loss could be beneficial in treatment of obesity.
Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Receptor de Melanocortina Tipo 3/metabolismo , gamma-MSH/metabolismo , Adiposidad , Animales , Peso Corporal , Dieta Occidental , Privación de Alimentos , Masculino , Ratones , Ratones Endogámicos C57BL , Actividad Motora , Obesidad/terapia , Pérdida de Peso , gamma-MSH/genéticaRESUMEN
Increased motivation for highly rewarding food is a major contributing factor to obesity. Most of the literature focuses on the mesolimbic nuclei as the core of reward behavior regulation. However, the lateral hypothalamus (LH) is also a key reward-control locus in the brain. Here we hypothesize that manipulating glucagon-like peptide-1 receptor (GLP-1R) activity selectively in the LH can profoundly affect food reward behavior, ultimately leading to obesity. Progressive ratio operant responding for sucrose was examined in male and female rats, following GLP-1R activation and pharmacological or genetic GLP-1R blockade in the LH. Ingestive behavior and metabolic parameters, as well as molecular and efferent targets, of the LH GLP-1R activation were also evaluated. Food motivation was reduced by activation of LH GLP-1R. Conversely, acute pharmacological blockade of LH GLP-1R increased food motivation but only in male rats. GLP-1R activation also induced a robust reduction in food intake and body weight. Chronic knockdown of LH GLP-1R induced by intraparenchymal delivery of an adeno-associated virus-short hairpin RNA construct was sufficient to markedly and persistently elevate ingestive behavior and body weight and ultimately resulted in a doubling of fat mass in males and females. Interestingly, increased food reinforcement was again found only in males. Our data identify the LH GLP-1R as an indispensable element of normal food reinforcement, food intake and body weight regulation. These findings also show, for we believe the first time, that brain GLP-1R manipulation can result in a robust and chronic body weight gain. The broader implications of these findings are that the LH differs between females and males in its ability to control motivated and ingestive behaviors.
Asunto(s)
Conducta Alimentaria/fisiología , Receptor del Péptido 1 Similar al Glucagón/fisiología , Área Hipotalámica Lateral/metabolismo , Animales , Peso Corporal , Condicionamiento Operante/efectos de los fármacos , Dieta Alta en Grasa , Ingestión de Alimentos/efectos de los fármacos , Femenino , Péptido 1 Similar al Glucagón/metabolismo , Receptor del Péptido 1 Similar al Glucagón/metabolismo , Hipotálamo/metabolismo , Masculino , Motivación/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Refuerzo en Psicología , RecompensaRESUMEN
This corrects the article DOI: 10.1038/mp.2016.203.
RESUMEN
Promoting adult hippocampal neurogenesis is expected to induce neuroplastic changes that improve mood and alleviate anxiety. However, the underlying mechanisms remain largely unknown and the hypothesis itself is controversial. Here we show that mice lacking Jnk1, or c-Jun N-terminal kinase (JNK) inhibitor-treated mice, display increased neurogenesis in adult hippocampus characterized by enhanced cell proliferation and survival, and increased maturation in the ventral region. Correspondingly, anxiety behaviour is reduced in a battery of tests, except when neurogenesis is prevented by AraC treatment. Using engineered retroviruses, we show that exclusive inhibition of JNK in adult-born granule cells alleviates anxiety and reduces depressive-like behaviour. These data validate the neurogenesis hypothesis of anxiety. Moreover, they establish a causal role for JNK in the hippocampal neurogenic niche and anxiety behaviour, and advocate targeting of JNK as an avenue for novel therapies against affective disorders.
Asunto(s)
Ansiedad/etiología , Proteína Quinasa 8 Activada por Mitógenos/metabolismo , Neurogénesis/fisiología , Afecto , Animales , Ansiedad/fisiopatología , Trastornos de Ansiedad/etiología , Trastornos de Ansiedad/metabolismo , Conducta Animal , Proliferación Celular , Depresión/etiología , Depresión/fisiopatología , Hipocampo/metabolismo , Hipocampo/fisiología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteína Quinasa 8 Activada por Mitógenos/genética , Neurogénesis/genética , Plasticidad Neuronal/fisiología , Neuronas/fisiologíaRESUMEN
AIM: Neuropeptide Y (NPY) co-localized with noradrenaline in central and sympathetic nervous systems seems to play a role in the control of energy metabolism. In this study, the aim was to elucidate the effects and pathophysiological mechanisms of increased NPY in catecholaminergic neurones on accumulation of body adiposity. METHODS: Transgenic mice overexpressing NPY under the dopamine-beta-hydroxylase promoter (OE-NPY(DßH) ) and wild-type control mice were followed for body weight gain and body fat content. Food intake, energy expenditure, physical activity, body temperature, serum lipid content and markers of glucose homoeostasis were monitored. Thermogenic and lipolytic responses in adipose tissues, and urine catecholamine and tissue catecholamine synthesizing enzyme levels were analysed as indices of sympathetic tone. RESULTS: Homozygous OE-NPY(DßH) mice showed significant obesity accompanied with impaired glucose tolerance and insulin resistance. Increased adiposity was explained by neither increased food intake or fat absorption nor by decreased total energy expenditure or physical activity. Adipocyte hypertrophy and decreased circulating lipid levels suggested decreased lipolysis and increased lipid uptake. Brown adipose tissue thermogenic capacity was decreased and brown adipocytes filled with lipids. Enhanced response to adrenergic stimuli, downregulation of catecholamine synthesizing enzyme expressions in the brainstem and lower adrenaline excretion supported the notion of low basal catecholaminergic activity. CONCLUSION: Increased NPY in catecholaminergic neurones induces obesity that seems to be a result of preferential fat storage. These results support the role of NPY as a direct effector in peripheral tissues and an inhibitor of sympathetic activity in the pathogenesis of obesity.
Asunto(s)
Neuronas Adrenérgicas/metabolismo , Neuropéptido Y/metabolismo , Obesidad/metabolismo , Sistema Nervioso Simpático/fisiología , Tejido Adiposo Pardo , Animales , Metabolismo Energético , Regulación de la Expresión Génica , Hipotálamo/metabolismo , Ratones , Ratones Transgénicos , Neuropéptido Y/genética , ARN Mensajero/genética , ARN Mensajero/metabolismoRESUMEN
The POMC pathway is involved in the regulation of energy and cardiovascular homeostasis in the hypothalamus and the brain stem. Although the acute effects of POMC-derived peptides in different brain locations have been elucidated, the chronic site-specific effects of distinct peptides remain to be studied. To this end, we used a lentiviral gene delivery vector to study the long-term effects of α-MSH in the nucleus tractus solitarius (NTS) of the brain stem. The α-MSH vector (LVi-α-MSH-EGFP) based on the N-terminal POMC sequence and a control vector (LVi-EGFP) were delivered into the NTS of C57BL/6N male mice fed on a western diet. Effects on body weight and composition, feeding, glucose metabolism, and hemodynamics by telemetric analyses were studied during the 12-week follow-up. The LVi-α-MSH-EGFP-treated mice had a significantly smaller gain in the fat mass compared with LVi-EGFP-injected mice. There was a small initial decrease in food intake and no differences in the physical activity. Glucose metabolism was not changed compared with the control. LVi-α-MSH-EGFP increased the heart rate (HR), which was attenuated by adrenergic blockade suggesting an increased sympathetic activity. Reduced response to muscarinic blockade suggested a decreased parasympathetic activity. Fitting with sympathetic activation, LVi-α-MSH-EGFP treatment reduced urine secretion. Thus, the results demonstrate that long-term α-MSH overexpression in the NTS attenuates diet-induced obesity. Modulation of autonomic nervous system tone increased the HR and most probably contributed to an anti-obesity effect. The results underline the key role of NTS in the α-MSH-induced long-term effects on adiposity and in regulation of sympathetic and parasympathetic activities.
Asunto(s)
Tejido Adiposo/metabolismo , Frecuencia Cardíaca/fisiología , Metabolismo de los Lípidos/fisiología , Núcleo Solitario/metabolismo , Regulación hacia Arriba/fisiología , alfa-MSH/metabolismo , Animales , Composición Corporal/fisiología , Peso Corporal/fisiología , Dieta Alta en Grasa/efectos adversos , Modelos Animales de Enfermedad , Glucosa/metabolismo , Hemodinámica/fisiología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Obesidad/etiología , Obesidad/prevención & control , alfa-MSH/genéticaRESUMEN
Melanocyte stimulating hormone (MSH) derived from the pro-hormone pro-opiomelanocortin (POMC) has potent effects on metabolism and feeding that lead to reduced body weight in the long-term. To determine the individual roles of POMC derived peptides and their sites of action, we created a method for the delivery of single MSH peptides using lentiviral vectors and studied the long-term anti-obesity effects of hypothalamic α-MSH overexpression in mice. An α-MSH lentivirus (LVi-α-MSH-EGFP) vector carrying the N'-terminal part of POMC and the α-MSH sequence was generated and shown to produce bioactive peptide in an in vitro melanin synthesis assay. Stereotaxis was used to deliver the LVi-α-MSH-EGFP or control LVi-EGFP vector to the arcuate nucleus (ARC) of the hypothalamus of male C57Bl/6N mice fed on a high-fat diet. The effects of 6-week-treatment on body weight, food intake, glucose tolerance and organ weights were determined. Additionally, a 14-day pairfeeding study was conducted to assess whether the weight decreasing effect of the LVi-α-MSH-EGFP treatment is dependent on decreased food intake. The 6-week LVi-α-MSH-EGFP treatment reduced weight gain (8.4 ± 0.4 g versus 12.3 ± 0.6 g; P < 0.05), which was statistically significant starting from 1 week after the injections. The weight of mesenteric fat was decreased and glucose tolerance was improved compared to LVi-EGFP treated mice. Food intake was decreased during the first week in the LVi-α-MSH-EGFP treated mice but subsequently increased to the level of LVi-EGFP treated mice. The LVi-EGFP injected control mice gained more weight even when pairfed to the level of food intake by LVi-α-MSH-EGFP treated mice. We demonstrate that gene transfer of α-MSH, a single peptide product of POMC, into the ARC of the hypothalamus, reduces obesity and improves glucose tolerance, and that factors other than decreased food intake also influence the weight decreasing effects of α-MSH overexpression in the ARC. Furthermore, viral MSH vectors delivered stereotaxically provide a novel tool for further exploration of chronic site-specific effects of POMC peptides.
Asunto(s)
Dieta , Hipotálamo/metabolismo , Lentivirus/fisiología , Obesidad/prevención & control , alfa-MSH/metabolismo , Animales , Secuencia de Bases , Cartilla de ADN , Prueba de Tolerancia a la Glucosa , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiologíaAsunto(s)
Trastornos Psicóticos/terapia , Trastornos Puerperales/terapia , Femenino , Humanos , Lactante , Recién Nacido , Relaciones Madre-Hijo , Atención Posnatal/normas , Embarazo , Pronóstico , Trastornos Psicóticos/diagnóstico , Trastornos Psicóticos/psicología , Trastornos Puerperales/diagnóstico , Trastornos Puerperales/psicología , Factores de Riesgo , Apoyo Social , EspososRESUMEN
The authors examined a family in which father and son presented with pars planitis. Both of them and the paternal grandparents were HLA typed; no association between HLA antigens and pars planitis was found. Present and previous data suggest a relation between pars planitis and allergic predisposition.
Asunto(s)
Pars Planitis/genética , Corticoesteroides/uso terapéutico , Preescolar , Padre , Enfermedades Genéticas Congénitas , Prueba de Histocompatibilidad , Humanos , Masculino , Pars Planitis/tratamiento farmacológico , Linaje , Agudeza Visual , Cuerpo Vítreo/citología , Cuerpo Vítreo/efectos de los fármacosRESUMEN
We studied two patients with a peculiar congenital disturbance of ocular motility in which the horizontal movements of the left eye were always opposite the normal expected direction. The common features were: (1) congenital monocular adduction palsy and exotropia of the left eye; (2) simultaneous abduction of both eyes (divergence) on attempted dextroversion; (3) ocular torticollis, head turned to the right; and (4) inverse nystagmus of the left eye, occurring spontaneously as well as during optokinetic and vestibular testing. Clinical and electrooculographic findings suggested a close relationship to Duane's retraction syndrome and supported the concept that innervational mechanisms were responsible for the phenomenon.
Asunto(s)
Exotropía/congénito , Oftalmoplejía/congénito , Estrabismo/congénito , Adulto , Preescolar , Electrooculografía , Femenino , Fijación Ocular , Humanos , Masculino , Nistagmo Patológico/fisiopatología , Oftalmoplejía/fisiopatología , Movimientos SacádicosRESUMEN
We describe six related patients presenting with an autosomal dominantly inherited pattern dystrophy of the retinal pigment epithelium, significantly abnormal electro-oculogram and minor colour vision abnormalities. There is a continuum of variable phenotypic expression within the pattern dystrophies of the retinal pigment epithelium.
Asunto(s)
Epitelio Pigmentado Ocular/patología , Degeneración Retiniana/genética , Adolescente , Adulto , Aberraciones Cromosómicas/patología , Trastornos de los Cromosomas , Defectos de la Visión Cromática/genética , Defectos de la Visión Cromática/patología , Electrooculografía , Femenino , Angiografía con Fluoresceína , Humanos , Masculino , Persona de Mediana Edad , Linaje , Degeneración Retiniana/patologíaRESUMEN
The authors describe a family with atypical sector shaped pigmentary dystrophy in two generations with transmission from father to son. A review of the literature is given.
Asunto(s)
Retinitis Pigmentosa/genética , Adulto , Niño , Pruebas de Percepción de Colores , Adaptación a la Oscuridad , Electrooculografía , Electrorretinografía , Femenino , Fondo de Ojo , Humanos , Masculino , Persona de Mediana Edad , Linaje , Retinitis Pigmentosa/patología , Retinitis Pigmentosa/fisiopatología , Campos VisualesRESUMEN
Two siblings had atrophic maculopathy associated with hereditary ataxia clinically defined as an olivopontocerebellar degeneration. The macular changes were suggestive of an early bull's-eye maculopathy in one case and of a late atrophic stage of bull's-eye maculopathy in the other. This suggests that concentric annular (bull's-eye) macular dystrophy may occur as part of olivopontocerebellomacular degeneration. Exogenous causes were excluded. The inheritance pattern was autosomal recessive or irregular autosomal dominant. The relationship of these two degenerative disorders is not yet clear. This combination of findings has been, to our knowledge, only rarely described.